| AP | Aerobic performance |
| AR | Active recovery |
| AR | Androgen receptor |
| AT | Anaerobic threshold |
| ATM | Ataxia telangiectasia mutated |
| ATP | Adenosine triphosphate |
| CAT | Catalase |
| CB1 and CB2 | Cannabinoid receptors 1 and 2 |
| CBF | Cerebral blood flow |
| CCO | Cytochrome c oxidase |
| cDNA | Complementary DNA |
| CINC-1 | Cytokine-induced neutrophil chemoattractant-1 |
| CK | Creatine kinase |
| CMJ | Counter movement jump |
| COD | Crossover design |
| CON | Concentric |
| COX-1/COX-2 | Cyclooxygenases- 1 and -2 |
| Cr | Creatine |
| CS | Citrate synthase |
| CSA | Larger cross-sectional area |
| CW | Continuous wave |
| CWI | Cold water immersion |
| DOMS | Delayed onset muscle soreness |
| ECC | Eccentric |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase primers |
| GPCRs | G-protein-coupled receptors |
| GPx | Glutathione peroxidase |
| HFD | High-fat diet |
| HI | Neonatal hypoxia-ischemia |
| HPRT | Hypoxanthine-guanine phosphoribosyl transferase |
| HR | Heart rate |
| HRV | Heart rate variability |
| HSI | Hamstring strain injury |
| ICC | Intra-class correlation coefficient |
| IL-10 | Interleukin 10 |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| IMP | Impulse |
| IR | Infrared |
| iVO2MAX | Intensity at which VO2MAX was reached |
| KET test | Knee extension test |
| La−P | Peak lactate concentration after exercise |
| LDH | Lactate dehydrogenase |
| LEDs | Light-emitting diodes |
| LEDT | Light-emitting diode therapy |
| LFD | Low-fat diet |
| MAOD | Maximal accumulated oxygen deficit |
| MAODALT | Alternative maximal accumulated oxygen deficit |
| MAP-2 | Microtubule-associated protein-2 |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MDA | Level of malondialdehyde |
| MHFAKE | Maximal hip flexion active knee extension |
| MMPs | Matrix metalloproteinases |
| MOP | Mean output power |
| MPO | Myeloperoxidase |
| MRF4 | Myogenic regulatory factor (herculin) |
| MRS | Maximum running speed |
| mT | mili Testa (magnetic field) |
| mTOR | Mammalian (or mechanistic) target of rapamycin |
| MVC | Maximum voluntary contraction |
| myHC | Myosin heavy chain |
| NMES | Neuromuscular electrical stimulation |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| OA | Osteoarthritis |
| P200 | Performance of 200 m |
| P53 | Tumor protein p53 |
| PBMT | Photobiomodulation therapy |
| PCR | Polymerase chain reaction |
| PF | Peak force |
| PGE2 | Prostaglandin E2 |
| PNS | Peripheral nerve stimulation |
| PPO | Peak power output |
| PSLR | Passive straight leg raise |
| PV | Peak velocity |
| R | Red |
| RCT | Double-blind randomized controlled trial |
| REREX | Exhaustion respiratory exchange ratio |
| RCTs | Placebo-controlled randomized trials |
| RPE | Rating of perceived exertion |
| RPEex | Exhaustion perceived exertion |
| SIT | Sprint interval training |
| SJ | Squat jump |
| SLR | Straight leg raise |
| sMF | Static magnetic field |
| SmO2 | Muscle oxygen saturation |
| SOD | Superoxide dismutase |
| SSC | Stretch-shortening cycle |
| TAC | Total antioxidant capacity |
| TBARS | 2-thiobarbituric acid |
| TNF-α | Tumor necrosis factor-alpha |
| TRF1/TRF2 | Telomeric repeat binding factors |
| VCO2 | Volume carbon dioxide |
| VO2 | O2 uptake |
| VO2EX | Exhaustion oxygen consumption |
| VO2MAX | Maximal oxygen uptake |
| YYIR1 | YoYo intermittent recovery level 1 |
| 1-RM | Load in 1-repetition maximum test |
| 30 CJ | 30-s crossbar jump test |
| ↑ | Increase |
| ↓ | Decrease |